https://www.4sfreedomgroup.com/covid-19-resource-d

New Post Public Reply Private Reply Replies (1) Message Board
Crunch55
422
https://www.4sfreedomgroup.com/covid-19-resource-docs

MEDICAL PROFESSIONALS RESOURCE PDF DOCUMENTS
SARS-CoV-2 Innova Rapid Qualitative Antigen Test Product Insert
SAS-COV-2 Innova Antigen Rapid Qualitative Test Kit Clinical Report
SARS-Cov-2-Innova Antigen Test IFU
Oxford University Innova Rapid Test Study Data
Oxford University - Rapid Antigen Study Results
SARS-Cov-2-Access Bio-CareStart Product Insert
FDA EUA Document - Access Bio - CareStart Antigen Kit
Access Bio - CareStart Kit Health Care Provider
Access Bio - CareStart Kit Patient Info
Access Bio CareStart Antigen Kit FIU
Novel Coronavirus-19-nCoV-RT-PCR Detection Kit PPT
EUA Xiamen Biotime FDA Letter
EUA Maccura SARS FIU
CLIA Waived EUA Authorized Testing of COVID-19
YOU HAVE QUESTIONS, WE HAVE ANSWERS
What test are used to diagnose COVID-19?







Are all coronavirus test kits FDA (EUA) authorized that will move through our distribution pipeline?

Is shipping available internationally?

What are the benefits of constant testing?

What is the pricing structure for consultancy and diagnostic testing tools?


Can you tell me more about the antibody test kits?







What about the Rapid Antigen Test?


What about the PCR tests?







What are the costs of the test kits?

Anything new that we are working on?
We have a couple of exciting things that we are moving forward with; a partnership with the National Center for Disaster Preparedness.

We have also created an application that can be downloaded via app store or android store that gives organizations and companies the ability to implement testing schedules and
protocols. This will be done at the organizational level and not per individual like what you are seeing out there. People do not want their personal information being available to everyone, this does not collect personal information but does address the need for testing, tracing and
accountability.

Lastly, we invested several million $$ in acquiring a manufacturing facility in Brea, CA to start making the rapid antigen test kits which will increase our production to about 2M kits per day by Oct 15th

Quantum Materials Corp. (QTMM) Stock Research Links

QTMM Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

BIC's Latest Voting Rights and Shares Disclosure Details

Updated Category News Views 180

Key Disclosure on Voting Rights and Shares As a reputable leader in stationery and consumer products, BIC is committed to transparency. Recently, they provided crucial insights into their corporate structure, particularly regarding the total number of voting rights and shares. This disclosure highlights the ongoing dedication towards maintaining clear communication with...

Continue Reading
AGCO Showcase: Innovations and Autonomy for 2026 Farmers

Updated Category News Views 212

AGCO (NYSE: AGCO) is strutting its stuff at the 2026 Commodity Classic in San Antonio from February 25-27. Picture this: over 24,000 square feet jam-packed with cutting-edge agricultural machinery aimed at farmers who want to boost their operations. Yeah, the buzz is all about showcasing their big guns like Fendt®, Massey Ferguson®, and PTx™—but dig deeper into...

Continue Reading
Revolutionizing Healthcare Marketing with Ignite Pulse Solutions

Updated Category News Views 371

Revolutionizing Healthcare Marketing with Ignite Pulse Solutions In the shifting landscape of healthcare marketing, WebMD Ignite introduces a significant enhancement aimed at assisting health systems in thriving amidst the challenges posed by AI and budget constraints. Presenting Ignite Pulse™, this groundbreaking solution offers a comprehensive growth strategy designed...

Continue Reading
Eupraxia Pharmaceuticals Welcomes New Leaders to Innovate Growth

Updated Category News Views 190

Eupraxia Pharmaceuticals Expands Leadership Team Eupraxia Pharmaceuticals Inc. (TSX: EPRX) (NASDAQ: EPRX), known for its innovative approaches in drug delivery technology, has recently announced two significant additions to its leadership. Dr. Amanda Malone has been appointed as the Chief Operating and Scientific Officer, alongside Dr. Rahul Sarugaser as Executive Vice...

Continue Reading
Illumina Enhances Oncology Solutions for Better Cancer Care

Updated Category News Views 186

Illumina's Latest Developments in Oncology In an exciting development, Illumina Inc. (NASDAQ: ILMN) has announced a significant expansion in its clinical oncology portfolio. This move aims to set a new standard of care and enhance access to precision therapies through advanced genomic profiling. Following the recent FDA approval of Illumina's TSO Comprehensive test, the...

Continue Reading